Patients with type 2 diabetic nephropathy are more likely to progress to end-stage renal disease (ESRD) than die, according to investigators.
In a retrospective study of 3,228 adults with type 2 diabetic nephropathy, ESRD developed in 19.5% of subjects over a mean follow-up period of 2.8 years, which was 2.5 times the incidence of cardiovascular death and 1.5 times the incidence of all-cause mortality, researchers reported online in the American Journal of Kidney Diseases.
A team led by Hiddo J. Labers Heerspink, PharmD, PhD, of the University Medical Center Groningen in Groningen, the Netherlands, concluded that their findings have implications for predicting future renal replacement requirements because of the rapidly increasing number of cases of type 2 diabetes worldwide.
Continue Reading
The study found that ESRD occurred more commonly than cardiovascular death in all subgroups analyzed, except for subjects with low levels of albuminuria and well-preserved levels of renal function.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.